Business Description
Estrella Immunopharma is a US-based medical company focused on developing T-cell treatments for patients with blood cancers and other tumors. Its pipeline includes three candidates ? EB103, EB104, and EB201 ? targeting conditions such as large B-cell lymphoma, acute lymphocytic leukemia, and lupus, at various stages of clinical testing. The company operates its own cell receptor platform, called ARTEMIS, and works alongside Eureka Therapeutics and Imugene Limited to advance combination therapies for solid tumors. Founded in 2006 and based in Emeryville, California, Estrella operates as a subsidiary of Eureka Therapeutics.
